Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Dermatomyositis
In brief
This is a Phase 2/3, double-blind, randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of ravulizumab in adult participants with dermatomyositis (DM).
Key facts
- Study ID
- NCT04999020
- Run by
- Alexion Pharmaceuticals, Inc.
- People needed
- 38
- Starts
- 2021-11-19
- Expected to finish
- 2024-05-08
- Last updated by the study team
- 2025-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Irvine, California, United States
- Research Site — Santa Monica, California, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Tampa, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Fairway, Kansas, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Las Vegas, Nevada, United States
- Research Site — Manhasset, New York, United States
- Research Site — New York, New York, United States
- Research Site — Chapel Hill, North Carolina, United States
- Research Site — Durham, North Carolina, United States
- Research Site — Cleveland, Ohio, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Charleston, South Carolina, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — North Richland Hills, Texas, United States
- Research Site — Seattle, Washington, United States
- Research Site — Camperdown, Australia
- Research Site — Murdoch, Australia
- Research Site — Belém, Brazil
- Research Site — Belo Horizonte, Brazil
- Research Site — Campinas, Brazil
- Research Site — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.